Goodyear Tire and Rubber, in Niagara Falls, is being fined $15,000 by the New York State Department of Environmental ...

The New Drug Application for TAR-200 is supported by results from the Phase IIb SunRISe-1 study, which demonstrated an 83.5% ...

Like all cancers, bladder cancer develops when abnormal cells start to multiply out of control. But what if we could put a ...

Patients with a common aggressive type of bladder cancer could get correct treatment significantly quicker as new research ...

The pharma began submitting its TAR-200 bladder cancer treatment to the FDA. Elsewhere, Sarepta and Madrigal reported strong ...

An FDA application for TAR-200 to treat BCG-unresponsive high-risk non-muscle-invasive bladder cancer is under real-time ...

Medical experts in Sheffield have hailed as a "game changer" trials of a drug that could reduce the recurrence of bladder ...

After adjusting for demographics, no significant difference in cancer risk was observed for patients with vitiligo and patients without vitiligo.

(RTTNews) - Johnson & Johnson (JNJ) Wednesday said it has initiated the submission of new drug application or NDA to Food and Drug Administration (FDA) for TAR-200 to treat patients with Bacillus ...

Johnson & Johnson (JNJ) said it has submitted an application to the FDA for its therapy candidate TAR-200 for the treatment of a certain type of bladder cancer. Read more here.

The New Brunswick, N.J., pharmaceutical giant said the FDA accepted the application through its Real-Time Oncology Review program, which allows for an earlier submission of topline efficacy and safety ...

A cancer-causing chemical is spewing into the air, in Niagara Falls, from the nearby Goodyear plant. That chemical is being ...